Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
3.
Mol Med Rep ; 19(6): 4890-4896, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-31059012

RESUMEN

The aim of this study was to investigate the protective effect of sulforaphane (SFN) on 1­methyl­4­phenyl pyridine ion (MPP+)­induced cytotoxicity and to investigate its possible mechanisms. METHODS: PC12 cell toxicity induced by MPP+ served as a cell model of Parkinson's diseases. The cell culture + experiments were divided into four groups based on the different treatments, namely, vehicle control, SFN, MPP+ and SFN pretreatment plus MPP+. Cell viability and apoptosis were examined by MTT assay and flow cytometry, respectively. Expressions of nuclear factor erythroid 2­related factor 2 (Nrf2), heme oxygenase 1 (HO­1) and nicotinamide quinone oxidoreductase 1 (NQO1) were detected using western blotting. RESULTS: MPP+ reduced the survival rate of PC12 cells in a dose­ and time­dependent manner. After 24­h treatment with 500 µmol/l MPP+, the survival rate of PC12 cells decreased to 58.2±0.03% of that in the control groups. Under the same conditions MPP+ resulted in significant apoptosis of PC12 cells (apoptosis rate: 30.4±0.6%). However, SFN pretreatment significantly attenuated the cell damage induced by MPP+. Furthermore, it was demonstrated that SFN reversed the reduction of Nrf2, HO­1 and NQO1 expression induced by MPP+. CONCLUSION: SFN may protect PC12 cells from MPP+­induced damage via activating the Nrf2­ARE (antioxidant responsive element) pathway.


Asunto(s)
Isotiocianatos/farmacología , Factor 2 Relacionado con NF-E2/metabolismo , Estrés Oxidativo/efectos de los fármacos , Células PC12/efectos de los fármacos , Sustancias Protectoras/farmacología , 1-Metil-4-fenilpiridinio/toxicidad , Animales , Elementos de Respuesta Antioxidante , Antioxidantes/farmacología , Antiparkinsonianos/farmacología , Apoptosis/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Hemo-Oxigenasa 1/metabolismo , Isotiocianatos/administración & dosificación , NAD(P)H Deshidrogenasa (Quinona)/metabolismo , Enfermedad de Parkinson/tratamiento farmacológico , Ratas , Especies Reactivas de Oxígeno/metabolismo , Transducción de Señal/efectos de los fármacos , Sulfóxidos , Tasa de Supervivencia , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA